New oral anticoagulants for atrial fibrillation: The factor Xa inhibitors rivaroxaban and apixaban

Russell S. Roberson, Andrew D. Shaw

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)e46-e48
JournalReviews in Cardiovascular Medicine
Volume13
Issue number1
DOIs
StatePublished - Jul 4 2012

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this